Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
UNIVERSITE COTE D'AZUR currently has 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among distinct examiners, meaning each pending application is being reviewed by a different official. The prosecution is also spread across 3 distinct art units, which suggests a diverse range of technical topics within the university's biotechnology research. The busiest examiner for the university is RZECZYCKI, PHILLIP MATTHEW, who is currently handling 1 busiest examiner pending action.
Because the workload is split between distinct examiners and 3 distinct art units, the university must manage separate prosecution strategies. This lack of concentration means the university's success in the Biotechnology & Pharmaceuticals sector depends on navigating the different standards and feedback of separate patent office officials simultaneously. The 1 busiest examiner pending action assigned to RZECZYCKI, PHILLIP MATTHEW represents a specific portion of the 3 pending office actions total. This distribution requires a strategy that balances individual examiner preferences with the unified standards of the university's research goals.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RZECZYCKI, PHILLIP MATTHEW | 1 | 64.8% | +37.0% |
| JOHANSEN, PETER N. | 1 | 59.3% | +24.4% |
| PATEL, NIKETA I | 1 | 41.1% | +8.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17967436 | Treatment of Type 1 Diabetes | PATEL, NIKETA I | 15d |
| 18266713 | SQSTM1 AND ITS USE IN CANCER THERAPY | JOHANSEN, PETER N. | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18577572 | COMPOUND OF THE 7A,8,9,10,11,11A-HEXAHYDRO-1H,7H-PYRANO[2,3-C]XANTHENE TYPE, METHOD OF PREPARATION THEREOF, INTERMEDIATES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF | RZECZYCKI, PHILLIP MATTHEW | — |
| 18266713 | SQSTM1 AND ITS USE IN CANCER THERAPY | JOHANSEN, PETER N. | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1644 | 1 |
| 3792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18577572 | COMPOUND OF THE 7A,8,9,10,11,11A-HEXAHYDRO-1H,7H-PYRANO[2,3-C]XANTHENE TYPE, METHOD OF PREPARATION THEREOF, INTERMEDIATES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF | RZECZYCKI, PHILLIP MATTHEW | 1625 | §112 | Final Rejection | — | Pending | Jan 08, 2024 |
| 18266713 | SQSTM1 AND ITS USE IN CANCER THERAPY | JOHANSEN, PETER N. | 1644 | §101§103 | Final Rejection | — | Pending | Jun 12, 2023 |
| 17967436 | Treatment of Type 1 Diabetes | PATEL, NIKETA I | 3792 | §102§103 | Non-Final OA | 15d | Pending | Oct 17, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial